RGD-dependent Binding of Procathepsin X to Integrin αvβ3 Mediates Cell-adhesive Properties

Annette Lechner, Irmgard Assfalg‐Machleidt, Stefan Zahler, Mechthild Stoeckelhuber, Werner Machleidt, Marianne Jochum, Dorit K. Nägler

Journal of Biological Chemistry · 2006 · 103 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

Secreted lysosomal cysteine proteases (cathepsins) are involved in degradation and remodeling of the extracellular matrix, thus contributing to cell adhesion and migration. Among the eleven human lysosomal cysteine proteases, only procathepsin X contains an RGD motif located in a highly exposed region of the propeptide, which may allow binding of the proenzyme to RGD-recognizing integrins. Here, we have tested procathepsin X for cell-adhesive properties and found that it supports integrin αvβ3-dependent attachment and spreading of human umbilical vein endothelial cells. Using site-directed mutants of procathepsin X, we proved that this effect is mediated by the RGD sequence within the proregion of the protease. Endogenous procathepsin X is transported to the plasma membrane, accumulates in vesicles at lamellipodia of the human umbilical vein endothelial cell, and is partly associated with the cell surface, as shown by immunofluorescence. In addition, procathepsin X is partly co-localized with integrin β3, as detected by immunogold electron microscopy. A direct interaction between endogenous procathepsin X and αvβ3 was demonstrated by co-immunoprecipitation. Moreover, surface plasmon resonance analysis revealed significant and RGD-dependent binding of procathepsin X to integrin αvβ3. Our results provide for the first time evidence that the extracellular function of cathepsin X may include binding to integrins thereby modulating the attachment of migrating cells to ECM components. Secreted lysosomal cysteine proteases (cathepsins) are involved in degradation and remodeling of the extracellular matrix, thus contributing to cell adhesion and migration. Among the eleven human lysosomal cysteine proteases, only procathepsin X contains an RGD motif located in a highly exposed region of the propeptide, which may allow binding of the proenzyme to RGD-recognizing integrins. Here, we have tested procathepsin X for cell-adhesive properties and found that it supports integrin αvβ3-dependent attachment and spreading of human umbilical vein endothelial cells. Using site-directed mutants of procathepsin X, we proved that this effect is mediated by the RGD sequence within the proregion of the protease. Endogenous procathepsin X is transported to the plasma membrane, accumulates in vesicles at lamellipodia of the human umbilical vein endothelial cell, and is partly associated with the cell surface, as shown by immunofluorescence. In addition, procathepsin X is partly co-localized with integrin β3, as detected by immunogold electron microscopy. A direct interaction between endogenous procathepsin X and αvβ3 was demonstrated by co-immunoprecipitation. Moreover, surface plasmon resonance analysis revealed significant and RGD-dependent binding of procathepsin X to integrin αvβ3. Our results provide for the first time evidence that the extracellular function of cathepsin X may include binding to integrins thereby modulating the attachment of migrating cells to ECM components. Cellular migration through extracellular matrix (ECM) 2The abbreviations and trivial names used are: ECM, extracellular matrix; BSA, bovine serum albumin; cyclic RGD peptide, cyclo(-Arg-Gly-Asp-d-Phe-Val); cyclic RAD peptide, cyclo(-Arg-Gly-Ala-d-Phe-Val); DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline. 2The abbreviations and trivial names used are: ECM, extracellular matrix; BSA, bovine serum albumin; cyclic RGD peptide, cyclo(-Arg-Gly-Asp-d-Phe-Val); cyclic RAD peptide, cyclo(-Arg-Gly-Ala-d-Phe-Val); DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline. requires both cell adhesion to and proteolysis of ECM components. A large number of proteases, including matrix metalloproteases, serine proteases, but also lysosomal cysteine proteases are known to be responsible for ECM breakdown, particularly during tumor invasion (1Buck M.R. Karustis D.G. Day N.A. Honn K.V. Sloane B.F. Biochem. J. 1992; 282: 273-278Crossref PubMed Scopus (366) Google Scholar, 2Koblinski J.E. Ahram M. Sloane B.F. Clin. Chim. Acta. 2000; 291: 113-135Crossref PubMed Scopus (510) Google Scholar, 3DeClerck Y.A. Mercurio A.M. Stack M.S. Chapman H.A. Zutter M.M. Muschel R.J. Raz A. Matrisian L.M. Sloane B.F. Noel A. Hendrix M.J. Coussens L. Padarathsingh M. Am. J. Pathol. 2004; 164: 1131-1139Abstract Full Text Full Text PDF PubMed Scopus (197) Google Scholar). Cell adhesion to ECM on the other hand is largely mediated by heterodimeric cell surface receptors of the integrin family. Integrins are composed of noncovalently associated α and β chains that form various heterodimers with distinct adhesive specificities (4Arnaout M.A. Goodman S.L. Xiong J.P. Curr. Opin. Cell Biol. 2002; 14: 641-651Crossref PubMed Scopus (169) Google Scholar, 5Miranti C.K. Brugge J.S. Nat. Cell Biol. 2002; 4: E83-90Crossref PubMed Scopus (691) Google Scholar). Several proteases have been shown to mediate adhesion and migration of cells through interaction with integrins. Thus, prothrombin, the zymogen of a multifunctional serine protease of the blood coagulation system, interacts directly with integrins via its RGD sequence, a motif involved in integrin binding (6Byzova T.V. Plow E.F. J. Biol. Chem. 1997; 272: 27183-27188Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar, 7Byzova T.V. Plow E.F. J. Cell Biol. 1998; 143: 2081-2092Crossref PubMed Scopus (98) Google Scholar, 8Papaconstantinou M.E. Carrell C.J. Pineda A.O. Bobofchak K.M. Mathews F.S. Flordellis C.S. Maragoudakis M.E. Tsopanoglou N.E. Di Cera E. J. Biol. Chem. 2005; 280: 29393-29396Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar). Although the RGD sequence is partly buried in the native conformation (9Bode W. Turk D. Karshikov A. Protein Sci. 1992; 1: 426-471Crossref PubMed Scopus (648) Google Scholar), prothrombin can bind in an RGD-dependent fashion to integrins αIIbβ3 of platelets and αvβ3 of cultured human endothelial cells (10Bar-Shavit R. Sabbah V. Lampugnani M.G. Marchisio P.C. Fenton J.W. II Vlodavsky I. Dejana E. J. Cell Biol. 1991; 112: 335-344Crossref PubMed Scopus (81) Google Scholar, 11Stouffer G.A. Smyth S.S. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1971-1978Crossref PubMed Scopus (41) Google Scholar, 12Sajid M. Zhao R. Pathak A. Smyth S.S. Stouffer G.A. Am. J. Physiol. 2003; 285: C1330-C1338Crossref PubMed Scopus (19) Google Scholar). There is increasing evidence that interactions between prothrombin and β3 integrins play important roles in the regulation of hemostatic and vascular functions. Furthermore, the urokinase-type plasminogen activator/urokinase receptor (uPA/uPAR) system not only plays a key role in fibrinolysis but also regulates cell adhesion, cell migration, and cell proliferation through interaction with integrins (for review, see Refs. 13Mondino A. Blasi F. Trends Immunol. 2004; 25: 450-455Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar and 14Chapman H.A. Wei Y. Thromb. Haemostasis. 2001; 86: 124-129Crossref PubMed Scopus (117) Google Scholar). In this case, it is not the protease but its receptor uPAR that binds to β1 integrins and localizes urokinase to sites of cell attachment to ECM. Besides serine proteases, lysosomal cysteine proteases are also secreted from cells, particularly during tumor invasion and are known to degrade ECM (for review, see Ref. 15Jedeszko C. Sloane B.F. Biol. Chem. 2004; 385: 1017-1027Crossref PubMed Scopus (256) Google Scholar). An essential requirement for efficient degradation of ECM is the endoproteolytic activity displayed by most of the lysosomal cathepsins. Cathepsin X, however, a cysteine protease highly expressed in prostate cancer and gastric cancer (intestinal type) is a strict carboxypeptidase and therefore unlikely to participate in ECM degradation to a significant extent (16Nägler D.K. Zhang R. Tam W. Sulea T. Purisima E.O. Ménard R. Biochemistry. 1999; 38: 12648-12654Crossref PubMed Scopus (115) Google Scholar, 17Nägler D.K. Krüger S. Kellner A. Ziomek E. Ménard R. Buhtz P. Krams M. Roessner A. Kellner U. Prostate. 2004; 60: 109-119Crossref PubMed Scopus (70) Google Scholar, 18Krueger S. Kalinski T. Hundertmark T. Wex T. Kuster D. Peitz U. Ebert M. Nägler D.K. Kellner U. Malfertheiner P. Naumann M. Rocken C. Roessner A. J. Pathol. 2005; 207: 32-42Crossref PubMed Scopus (78) Google Scholar). Indeed, the inhibition of cathepsin X activity with anti-catalytic antibodies did not result in impaired migration of breast cancer cells (19Kos J. Sekirnik A. Premzl A. Zavasnik Bergant V. Langerholc T. Turk B. Werle B. Golouh R. Repnik U. Jeras M. Turk V. Exp. Cell Res. 2005; 306: 103-113Crossref PubMed Scopus (105) Google Scholar). Yet, as we have recently shown, inhibition of cathepsin X at the mRNA level leads to decreased migration of gastric epithelial cancer cells (18Krueger S. Kalinski T. Hundertmark T. Wex T. Kuster D. Peitz U. Ebert M. Nägler D.K. Kellner U. Malfertheiner P. Naumann M. Rocken C. Roessner A. J. Pathol. 2005; 207: 32-42Crossref PubMed Scopus (78) Google Scholar). This apparent contradiction led us to speculate that the enzyme may be involved in mechanisms of adhesion, migration, or invasion, which are not related to proteolysis. Interestingly, the crystal structure of procathepsin X reveals that the prosegment and its mode of inactivation of the protease are strikingly different when compared with the of other J. Nägler D.K. Zhang R. Ménard R. M. J. Biol. 2000; PubMed Scopus Google Scholar, M.R. R. J. M. 1998; PubMed Scopus Google Scholar). inhibition of the activity of the enzyme by the proregion is through a between the cysteine in the proregion and the cysteine RGD sequence in the proregion is lysosomal cysteine proteases and a surface with to the we that this motif may be important for the interaction of procathepsin X with integrins. to cathepsin X the RGD motif is in procathepsin X but not in the enzyme from as procathepsin X is in large the D.K. A.M. A. C. V. P. M. J. Immunol. PubMed Scopus Google Scholar), it was to speculate that procathepsin X can as an extracellular for integrins. In the we have demonstrated the of procathepsin X to with integrin αvβ3 through its RGD procathepsin X cell-adhesive attachment with human umbilical vein endothelial cells cells a of extracellular matrix receptors including integrin αvβ3. Our that binding to integrin αvβ3 via the of cathepsin X can adhesive properties of Moreover, procathepsin X accumulates at lamellipodia of endothelial cells and is partly co-localized with αvβ3. also a direct interaction between procathepsin X and integrin αvβ3 by of the endogenous from and by surface plasmon Thus, we provide first evidence that the extracellular function of cathepsin X may include of cell attachment to ECM through binding to integrins. and antibodies and from αIIbβ3 was from was from and from β3 was from cyclic and from procathepsin X was as D.K. Krüger S. Kellner A. Ziomek E. Ménard R. Buhtz P. Krams M. Roessner A. Kellner U. Prostate. 2004; 60: 109-119Crossref PubMed Scopus (70) Google Scholar). was from are in the and procathepsin X was expressed and as J. Nägler D.K. Zhang R. Ménard R. M. J. Biol. 2000; PubMed Scopus Google Scholar). the site-directed was on the the procathepsin X for the RAD and the of procathepsin X and by and the mutants expressed and as for the J. Nägler D.K. Zhang R. Ménard R. M. J. Biol. 2000; PubMed Scopus Google Scholar). Cell from cells to the in endothelial at in a with cells in and from cells by in a of was in at with of different in procathepsin X RGD RAD or as a with for at from the with at in and and of cells to by cells with various of cyclic RGD and RAD and or of antibodies αvβ3 or for at to the for at in with to the cells, the cells with for at with crystal for and with cells with and the was in a Furthermore, cells to the extent of cell attachment and and of the of and was at of X to the of and of by in for at with cells in in of serum and procathepsin X at for at for the was and the of procathepsin X was by as D.K. A.M. A. C. V. P. M. J. Immunol. PubMed Scopus Google Scholar). of the procathepsin was in the or of cells as as in the or of the integrin αvβ3 and as V. B.F. L. E. S. T. M. S. Am. J. Physiol. Scholar). cells cultured on cells for at with antibodies human procathepsin X D.K. Krüger S. Kellner A. Ziomek E. Ménard R. Buhtz P. Krams M. Roessner A. Kellner U. Prostate. 2004; 60: 109-119Crossref PubMed Scopus (70) Google integrin αvβ3 with cells with with PBS, and with antibodies with or with both from This was used to extracellular cells for with and for with by with PBS, with and with the cells with cells in a from the with at in endothelial cell was to and to for was as M. P. U. Cell Biol. 2002; PubMed Scopus Google Scholar). the of the for with the cells with and in for and with with for and with PBS, the cells with and serum for was by the cells with antibodies procathepsin X and integrin β3 for at at and for at be that the αvβ3 was for electron and was therefore by an the integrin β3 with and with the for at with of was for of procathepsin X and for of integrin β3 with for cells in in for and with with for and in a electron and that endothelial procathepsin X as a with used for of both from cells in endothelial for with with and at in was with at with the was and at for at was to the and the for at of was by at for and to the of the In binding of αvβ3 to procathepsin X and mutants the RGD motif was also by co-immunoprecipitation. αvβ3 was for at with procathepsin X in of and by at for and the as and as D.K. Krüger S. Kellner A. Ziomek E. Ménard R. Buhtz P. Krams M. Roessner A. Kellner U. Prostate. 2004; 60: 109-119Crossref PubMed Scopus (70) Google Scholar). antibodies used at of and antibodies used for for procathepsin X and for integrin be that to plasma of cell for not to the of the integrin its with procathepsin X during the surface plasmon was used to binding and for the interaction between different integrins and procathepsin X, or a of procathepsin X with its RGD sequence to was to the surface by the to the be that with integrins to the most to a conformation of the integrin heterodimers on the the cells the a and a was with a of in and at to the by of a of was at different in the between and This of was the a with was from the to binding and to an and a from the was from most by a for interaction between and to the for to a from the Protein and and the 1997; PubMed Scopus Google and was by the for as significant for the of by αvβ3 with that procathepsin X the may as an extracellular for integrins and to its adhesive we attachment with with procathepsin X, and cells to for shown in the cells to procathepsin X This attachment be with a cyclic RGD used as an the cyclic RAD effect at the results with a αvβ3 which binding to procathepsin Moreover, a integrin did not the adhesive that procathepsin X not bind to integrin This however, was to binding of to a matrix by not with procathepsin X mutants with the RGD motif to RAD or cathepsin X enzyme the RGD or of mediated attachment of of cells, to the extent of cell attachment and a of in with procathepsin X, most cells and to only a cells on with procathepsin X the RGD sequence of X to the of binding of procathepsin X to the surface of was also shown with cells in for in procathepsin X of procathepsin X was to have procathepsin X in plasma of to be in the of however, the procathepsin X are to of D.K. A.M. A. C. V. P. M. J. Immunol. PubMed Scopus Google of cells by the of procathepsin X was in the by In the of the integrin αvβ3 the of procathepsin X in the in the of the the of procathepsin X was of procathepsin X and also be a of procathepsin X, as we have detected the enzyme in vascular endothelial cells of different M. I. S. M. W. M. and D. the of procathepsin X and a with integrin for both procathepsin X and αvβ3 and by immunofluorescence. of procathepsin X was of the extracellular cells with antibodies to was not detected on the of cells, most of for of the cells with revealed of procathepsin X and with particularly at lamellipodia and be that of procathepsin X and αvβ3 is to vesicles associated with the plasma membrane, that the not within the vesicles not with vesicles for associated with the plasma with cells to be to an with antibodies not with only of the antibodies procathepsin X or αvβ3 did not of the used for of the other not in the of procathepsin X and integrin αvβ3 on the surface of endothelial cells, immunogold extracellular cells not with of with and electron microscopy. immunogold revealed a of procathepsin X and β3 particularly at lamellipodia of of to X on the cell surface with the integrin β3 and was in antibodies not of X and endothelial procathepsin X is associated with endogenous integrin we endogenous αvβ3 from and the by for procathepsin Indeed, endogenous procathepsin X from of cell that with X antibodies with the form the enzyme to a of In the however, the form to the proenzyme was This the of the the RGD sequence is located within the proregion of cathepsin X, and the form of cathepsin X therefore not be to bind to αvβ3. integrin β3 was detected at the of in the first and first was to the integrin β3, the used for binds to the and β3 may also form heterodimers with α other have also used the as as mutants with the RGD sequence to RAD or in a procathepsin X is detected in the with antibodies αvβ3. In procathepsin X mutants the RGD sequence did not with the of X to the procathepsin the binding of procathepsin X to integrins in to other was by surface plasmon procathepsin X, a of procathepsin X with its RGD sequence to and on a the was used to binding and for the interaction with different integrins procathepsin X and to αvβ3 in a with in the of A and to a binding as In to the different of the procathepsin X the RGD sequence binding interaction of procathepsin X or with αvβ3 be with the cyclic RGD peptide, on the interaction between the procathepsin X and αvβ3 was binding of procathepsin X to αvβ3. plasmon resonance was used in a with the cyclic RGD the of of αvβ3 in binding for both and procathepsin X with the cyclic RGD the binding for both that the RGD with and procathepsin X for binding to αvβ3. was with the of the cyclic RGD was used as the was for and was by for the of αvβ3 to procathepsin X or as as the highly on the of particularly not at was also used to the binding of the different to αvβ3 with that to other αIIbβ3 and receptor for but not for to we detected binding of both procathepsin X and binding was with the the RGD sequence binding of and procathepsin X to integrin was and mechanisms function in a to provide cell migration and are during and as and tumor cell invasion Curr. Opin. Cell Biol. PubMed Scopus Google Scholar, I. J. Pathol. 2003; PubMed Scopus Google Scholar, B. B. R. M. W. N.E. P. J. Cell Biol. 2004; PubMed Scopus Google Scholar, T. 2005; PubMed Scopus Google Scholar). the adhesion receptors are displayed on the cell surface and bind to ECM proteases matrix metalloproteases, cysteine or degrade of the ECM. proteases have also been to with cell adhesion migration in a fashion M.E. Carrell C.J. Pineda A.O. Bobofchak K.M. Mathews F.S. Flordellis C.S. Maragoudakis M.E. Tsopanoglou N.E. Di Cera E. J. Biol. Chem. 2005; 280: 29393-29396Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 13Mondino A. Blasi F. Trends Immunol. 2004; 25: 450-455Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar, P.C. S. J.P. Full Text Full Text PDF PubMed Scopus Google Scholar). In this we have of evidence that the cysteine protease procathepsin X is of with integrin αvβ3 through an RGD-dependent we have shown that procathepsin X is to the cell-adhesive properties of which be with antibodies to αvβ3 but not with antibodies to Moreover, procathepsin X at is also to bind to endothelial cells in in an integrin αvβ3-dependent and immunogold electron we have demonstrated of procathepsin X and with αvβ3 at the lamellipodia of of procathepsin X and αvβ3 from a of the in a surface plasmon we have shown that procathepsin X is to bind directly to integrin αvβ3. in results that procathepsin X is to form a with integrin and we that this interaction may in as thereby cell adhesion and also migration In this of we have shown recently that of human gastric epithelial tumor cells through ECM can be the cells are with cathepsin X (18Krueger S. Kalinski T. Hundertmark T. Wex T. Kuster D. Peitz U. Ebert M. Nägler D.K. Kellner U. Malfertheiner P. Naumann M. Rocken C. Roessner A. J. Pathol. 2005; 207: 32-42Crossref PubMed Scopus (78) Google Scholar). of through human ECM is also with cathepsin X not the other a of (19Kos J. Sekirnik A. Premzl A. Zavasnik Bergant V. Langerholc T. Turk B. Werle B. Golouh R. Repnik U. Jeras M. Turk V. Exp. Cell Res. 2005; 306: 103-113Crossref PubMed Scopus (105) Google that inhibition of the activity of cathepsin X by antibodies not This apparent may be by that cathepsin X is a the enzyme be to participate in migration through ECM degradation to a significant of cathepsin X at the mRNA level however, be by of procathepsin X related to adhesion as a of the to be a for particularly a large number of integrins including αvβ3. binding of to the extracellular of integrins leads to and to integrin integrins to are M.A. Nat. Cell Biol. 2001; PubMed Scopus Google Scholar). Interestingly, as demonstrated procathepsin X accumulates in vesicles the at speculate that procathepsin X is transported through the the plasma of endothelial cells and also other cells, as or tumor cells, and is secreted to In cell procathepsin X is secreted the and an to between and M. I. S. M. W. M. and D. to however, procathepsin X is within the M. I. S. M. W. M. and D. This is in with a that the as a receptor for procathepsin X C. F. Nat. Cell Biol. 1999; 1: PubMed Scopus Google Scholar). be that other lysosomal cysteine proteases, and can also be to vesicles V. S. D. T. R. A. T. C. M. Biol. Chem. 2004; 385: PubMed Scopus Google Scholar, V. T. M. D. J. W. T. Biol. Chem. 2005; PubMed Scopus Google Scholar). X is the by endothelial cells as as by and D.K. A.M. A. C. V. P. M. J. Immunol. PubMed Scopus Google Scholar). we have shown by immunogold electron of procathepsin X and integrin β3 are associated with the cell both as as immunogold electron that a mode of procathepsin X with the plasma may an however, not by us may be the binding of procathepsin X to cell surface as by a I. Turk B. L. Biochem. 2005; PubMed Scopus Google Scholar). integrin on which is by Y. S. M. A. T. S. 1998; PubMed Scopus Google Scholar), procathepsin X interaction with integrins may be direct binding through its RGD sequence or through its binding to This binding mode may for the procathepsin X in the first as as for the of procathepsin X that is not co-localized with the integrin as shown by or immunogold electron mechanisms not cell may also procathepsin X from the cell surface to have to the mechanisms involved and the and for and of procathepsin Using and surface plasmon we to direct binding of procathepsin X to integrin αvβ3 in an RGD-dependent RGD motif of procathepsin X is highly exposed within a surface of the proregion J. Nägler D.K. Zhang R. Ménard R. M. J. Biol. 2000; PubMed Scopus Google Scholar, M.R. R. J. M. 1998; PubMed Scopus Google Scholar). conformation is strikingly to that of the cyclic RGD with the extracellular of integrin αvβ3 J.P. T. Zhang R. A. M. Goodman S.L. M.A. 2002; PubMed Scopus Google and allow a binding mode the cyclic was to with procathepsin X in surface plasmon resonance This is evidence for the of the interaction between procathepsin X and integrins. through the RGD sequence in the however, that binding of the RGD motif to the integrin the of the the interaction between procathepsin X and integrin αvβ3 is highly on the of in of is a known that integrins are by to an conformation that binding to adhesive J.W. D. J. Biol. Chem. Full Text PDF PubMed Google Scholar). Interestingly, we that both and procathepsin X of for RGD-dependent interaction with integrins. the was but was not also be that the of for integrins by surface plasmon resonance is with a for αvβ3 and αIIbβ3 1992; Full Text PDF PubMed Scopus Google Scholar). to the of in in that of procathepsin X in human plasma between and D.K. A.M. A. C. V. P. M. J. Immunol. PubMed Scopus Google Scholar). the for the interaction of procathepsin X with integrin αvβ3 in the of for a of proenzyme to αvβ3. This interaction may be of particularly at sites of or at the of a of procathepsin X may be In an procathepsin X may be to with for the binding to integrin αvβ3. we have shown, procathepsin X is highly in both and of prostate cancer D.K. Krüger S. Kellner A. Ziomek E. Ménard R. Buhtz P. Krams M. Roessner A. Kellner U. Prostate. 2004; 60: 109-119Crossref PubMed Scopus (70) Google Scholar). the other integrin αvβ3 been in and is also expressed in and including prostate it plays a role in tumor cell and R. L. M. Res. Google Scholar, J. Clin. 1991; PubMed Scopus Google Scholar, 2002; 4: PubMed Google Scholar). to αvβ3 in endothelial cells, thereby in (for review, see Refs. Curr. 2003; 4: PubMed Scopus Google Scholar and C. A. Acta. 2004; Google Scholar). are to the of procathepsin X and its interaction with integrins during tumor invasion and In results provide first evidence that the RGD motif in the proregion of the lysosomal cysteine protease cathepsin X can mediate adhesion and also migration via binding to integrins. this to be In of the may to the role of procathepsin X at the and for

References

29